RxDoctor Payments Data

Erin McGonigle, MD

Physical Medicine & Rehabilitation · Milwaukee, WINPI 1740575828

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $24,635 and has fallen 97.7% since, to $555 in 2025. Among physical medicine & rehabilitation clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,035in general payments, 2019–2025

Across 183 payments — averaging $360.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$48K
  • Merz North America, Inc.$10K
  • Merz Pharmaceuticals, LLC$4K
  • Ipsen Biopharmaceuticals, Inc$1K
  • Ipsen Pharma SAS$674
  • AstraZeneca$370
  • plus $793 from 5 others
$1,687in research payments, 2019–2025

Across 7 payments — averaging $241.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merz North America, Inc.$2K
  • Merz Pharmaceuticals, LLC$137

What the payments were for

  • Consulting fees$19,98730%
  • Speaking & faculty fees$29,78845%
  • Travel & lodging$7,01211%
  • Food & beverage$9,24914%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)85$47,992
Merz North America, Inc.37$10,393
Merz Pharmaceuticals, LLC34$4,441
Ipsen Biopharmaceuticals, Inc14$1,372
Ipsen Pharma SAS3$674
AstraZeneca3$370
Pacira Pharmaceuticals Incorporated2$327
Amgen(2 entities)2$222
MDD US Operations, LLC1$119
Medtronic1$115
Dynasplint Systems Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,035 in reported general payments places this provider in the 95th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.

See all physical medicine & rehabilitation providers in Wisconsin

Medicare billing

Part B allowed, 2024
$41,333
Medicare patients
139
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen60$2,292
Dantrolene Sodium14$1,768
Gabapentin34$1,256
Tizanidine Hcl26$799

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →